SEC EDGAR CompanyFacts fact · reporting period
AVALO THERAPEUTICS, INC.: revenue
One fact, its scope and the complete path back to the official record.
Reported value
$27.813M{"amount": 27813137, "concept": "us-gaap:Revenues", "currency": "USD"}- Entity
- AVALO THERAPEUTICS, INC.
- Metric
- revenue
- Period
- 2017-01-01 – 2017-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-09-01T14:07:51.298637+02:00
Raw response SHA-256
c27cef5388033067af62e0489a1b2af9…Official-identifier path
https://factanker.com/fact/sec/cik-0001534120/revenue/2017-12-31 (CIK, metric, reporting date)History
- supersedes {"amount": 27813137, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} (evidence 0001628280-19-003078)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.